Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Glaxo Group Ltd.

Home Clinical Trial Sponsors and OrganizationsGlaxo Group Ltd.

Glaxo Group Ltd.

ACTIVE

United Kingdomwww.gsk.com/en-gbSubsidiary10,001+ employeesEstablished: 1715-01-01

Part of glaxosmithkline finance plc

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

4

4 active

Approvals

3

Total approvals

Agencies

2

Regulatory bodies

Founded

1715

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

3

75.0%

Trial Status Distribution

Active, not recruiting

4

100.0%

Clinical Trials

Trials sponsored by this organization (4)

Study of subcutaneous Ofatumumab Injections for Pemphigus Vulgaris

Active, not recruiting

Jul 2015136 participants

Study of subcutaneous Ofatumumab Injections for Pemphigus Vulgaris

Active, not recruiting

Apr 2015136 participants

Study of subcutaneous Ofatumumab Injections for Pemphigus Vulgaris

Active, not recruiting

Dec 2014136 participants

Study of subcutaneous Ofatumumab Injections for Pemphigus Vulgaris

Active, not recruiting

Aug 2014136 participants

Approvals

Approvals by Agency

NMPA

National Medical Products Administration

2

Approvals

EMA

European Medicines Agency

1

Approvals

Recent Approvals

Umeclidinium Bromide Powder for Inhalation

Lamivudine Oral Solution

News

No news articles found

On this page

Overview
Clinical Trials4
Approvals3
News

Back to Organizations